🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
2.350
+0.030 (1.29%)
Nov 20, 2026, 4:00 PM EST - Market closed

Neuphoria Therapeutics Balance Sheet

Millions USD. Fiscal year is Jul - Jun.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Equivalents
18.7419.8714.2112.6112.123.13
Cash & Short-Term Investments
18.7419.8714.2112.6112.123.13
Cash Growth
37.32%39.79%12.71%4.17%-47.66%8.23%
Accounts Receivable
0.7-----
Other Receivables
-0.810.010.130.434.67
Receivables
0.70.810.010.130.434.67
Prepaid Expenses
0.160.390.740.460.81.01
Restricted Cash
--0.08---
Total Current Assets
19.621.0715.0413.1913.3328.81
Property, Plant & Equipment
--0.110.220.330.46
Goodwill
3.533.58.648.698.698.87
Other Intangible Assets
3.984.144.85.476.136.78
Other Long-Term Assets
---0.080.080.08
Total Assets
27.1128.7128.5927.6528.5645

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Accounts Payable
0.720.391.152.241.441.07
Accrued Expenses
0.360.282.881.391.191.13
Short-Term Debt
-0.030.030.03--
Current Portion of Leases
--0.120.120.110.11
Other Current Liabilities
-0.050.040.04--
Total Current Liabilities
1.090.764.223.832.742.31
Long-Term Leases
---0.120.240.37
Pension & Post-Retirement Benefits
-----0.01
Long-Term Deferred Tax Liabilities
0.320.360.50.961.11.24
Other Long-Term Liabilities
2.2334.875.252.471.86
Total Liabilities
3.634.119.5910.166.555.79

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Common Stock
0000-149.99
Additional Paid-In Capital
218.54218.46200.19198.48187.55-
Retained Earnings
-193.22-191.8-178.35-177.98-162.48-119.41
Comprehensive Income & Other
-1.84-2.06-2.85-3.01-3.068.63
Shareholders' Equity
23.4724.61917.4922.0139.21
Total Liabilities & Equity
27.1128.7128.5927.6528.5645

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Total Debt
-0.030.150.270.350.48
Net Cash (Debt)
18.7419.8314.0612.3411.7522.65
Net Cash Growth
38.52%41.03%13.99%4.99%-48.12%9.32%
Net Cash Per Share
3.614.518.6614.820.010.02
Filing Date Shares Outstanding
5.415.412.363,1181,4691,353
Total Common Shares Outstanding
5.415.411.982,3851,4691,353
Working Capital
18.5220.3110.829.3610.5926.49
Book Value Per Share
4.344.559.600.010.010.03
Tangible Book Value
15.9716.965.563.337.1923.57
Tangible Book Value Per Share
2.953.132.810.000.000.02
SEC Filings: 10-K · 10-Q